Advisory Board

Dr. Randall C. Walker

The VentureBeat article Live Ink offers better way to read text online said

Did you know our primitive brains weren’t wired very well to read this paragraph?
 
Scientific research conducted by Walker Reading Technologies, a small Minnesota startup that has been studying our ability to read for the last ten years, has concluded that the natural field of focus for our eyes is circular, so our eyes view the printed page as if we’re peering through a straw.
 
Walker Reading Technologies’ CEO and cofounder, Randall Walker MD, believes he and his team have developed a solution with a product called Live Ink that allows online publishers to improve reading speed and comprehension. Live Ink works by analyzing written language for meaning and language structure, and then applies algorithms that reformat the text into a series of short, cascading phrases. It breaks complex syntax into simpler syntax, which makes it easier for the brain to absorb the material.

Randall C. Walker, MD is President of WRT — Live Ink Reading Technologies which promotes the dynamic perception of word groups in a sentence, and to augment comprehension with multidimensional syntactic cueing patterns. The globally-patented Live Ink method is now featured in upper-elementary, secondary, and college level online textbooks, and received the 2005 Distinguished Achievement Award from the Association of Educational Publishers.
 
Randall coauthored Neurocognitive and classroom-based validation of computer-generated, visual-syntactic text formatting for college and high school reading, Live Ink®: Brain-Based Text Formatting Raises Standardized Reading Test Scores, Increased immunosuppression, not anticoagulation, extends cardiac xenograft survival, Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders, Disseminated Kaposi’s sarcoma after heart transplantation: association with Kaposi’s sarcoma-associated herpes virus, Transmission of invasive aspergillosis from a subclinically infected donor to three different organ transplant recipients, and Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations. Read his full list of publications.
 
He earned his B.A. at the University of Notre Dame and his M.D. at the Mayo Medical School.